Dec 16, 2022|
JD Pet Health Claps with US Brand Zesty Paws to Explore China’s Pet Market
by Vivian Yang
JD Pet Health, the pet care business under JD.com, and Zesty Paws, a US leading multi-condition pet supplement brand under H&H Group, have reached a ground-breaking cooperation agreement on cross-border sales in China.
The cooperation marks the top-rated US pet supplement brand entering Chinese market, with JD Pet Health being its first Chinese retail partner.
“We will continue to explore cooperation in the aspects of marketing, pet health education and more,” said Wenbo Tong, general manager of JD Pet Health. “The cooperation will be conducive to providing more science-based and targeted pet care products and services for pets and pet parents in China.”
Lately rebranded in November, JD Pet Health consolidated health products and medical services for pets as two core businesses to form a closed-loop, all-in-one pet care solution with both online and offline resources for Chinese users.
Founded in 2015, Zesty Paws offers a prime line of high-quality supplements for cats and dogs, represented by its bright-orange-bottle-packed star products, such as the Mobility Bites soft chews for dogs, Calming Bites for cats and more. It is currently the #1 best-selling multi-condition pet supplement brand online in the US, with successes in e-commerce channels like Amazon.com and Chewy.com.
This November, Zesty Paws made its debut in China during the fifth China International Import Expo that was held November 5 to 10 in Shanghai.
Data from the 2021 White Paper on China’s Pet Industry showed that China’s urban pet (dogs and cats) population has exceeded 112 million, boosting the consumption market scale to RMB 249 billion yuan by 2021, up 20.6 percent from 2020. With more Gen-Z consumers becoming pet parents, the growing market is eager for greater inspirations and innovations to make sure China’s fur-babies are healthy and happy.
(vivian.yang@jd.com)
Dec 13, 2024|
JD.com Targets 5 Billion RMB with Chilean Product Partnership as 2024/25 Season Cherry Sales Launch
On December 12, JD Super, the supermarket division of JD.com (also known as JINGDONG), launched the Chilean Specialties Festival and kicked off 2024/25 Chilean cherry sales with the recent arrival of the first “Cherry Express” ship in China. In a ceremony attended by the Chilean Ambassador to China, H.E. Mr. Mauricio Hurtado, JD Super signed a strategic cooperation agreement with Chilean brands, aiming to achieve 5 billion RMB in sales of Chilean products, including cherries, wine, and salmon, over the next three years.
The sea-freight Chilean cherry sales launch event was officiated by Ambassador Hurtado, Chao Junwen, Secretary-General of the China Chamber of Commerce for Foodstuffs and Native Produce, and Juan Latife, General Manager of Garces Fruit China, Chile’s leading cherry exporter.
Through large-scale direct sourcing, JD’s procurement team has reduced the import costs of Chilean cherries, offering consumers prices that are approximately 15% lower than those on other e-commerce platforms for the same grade and size.
To ensure quality and proper grading, JD Super has introduced a caliper offering this season. Each box of cherries comes with a caliper that allows consumers to accurately grade the fruit and ensure they have received high-quality Chilean cherries.
Since late October, JD’s online channels and its 7Fresh omnichannel supermarket chain have been selling the season’s air-freight Chilean cherries. This product offering, which has been met with enthusiasm from Chinese consumers, is supported by JD’s extensive national cold-chain logistics network and instant delivery services that can deliver orders within 30 minutes, making it easy and affordable for users to enjoy the early batch of Chilean cherries.
“This large-scale procurement cooperation will allow JD Super to continue leveraging our strong supply chain capabilities and work closely with Chilean partners to offer a wider variety of Chilean products at competitive prices and services to Chinese consumers,” said a spokesperson of JD Super.
(vivian.yang@jd.com)
Dec 12, 2024|
JD Health Debuts Merck’s New Diabetes Medication GLUCOPHAGE® XR (Reduce Mass) Online in China
On December 10, JD Health, in collaboration with Merck, a globally renowned biopharmaceutical leader, began offering GLUCOPHAGE® XR (Reduce Mass), the metformin hydrochloride extended-release tablets, and became the first online pharmacy in China to provide the new antidiabetic medication developed by Merck. This launch signifies a major milestone in the partnership between JD Health and Merck, which is dedicated to enhancing the online availability and accessibility of innovative treatments for type 2 diabetes patients in China, thereby offering them a more convenient and effective medication experience.
GLUCOPHAGE® has been a cornerstone in the treatment of type 2 diabetes for over 60 years worldwide. The latest version of this medication is designed to enhance patient adherence by reducing the long-term burden of medication administration while maintaining its therapeutic benefits. The use of GSD sustained-release technology extends the time the medication remains in the stomach, reduces gastrointestinal irritation, and improves drug absorption. Additionally, the tablet is now smaller, has reduced volume by 30%, and has been transitioned from a capsule to a round shape, making it easier to swallow. It requires only once-daily administration, significantly enhancing patient convenience and safety.
To celebrate the online launch collaboration, JD Health and Merck hosted a special release event for the new medication at the 7th China International Import Expo in November. This event followed their partnership agreement in September, which also marked the opening of Merck China’s self-operated flagship store on JD.com.
With a large user base, robust supply chain, and rich medical service resources, JD Health has become a preferred partner to launch many chronic disease medications online. By seamlessly integrating online and offline resources, JD Health ensures that new drug information reaches the right users swiftly, offering convenient purchasing options and improving drug accessibility and usage efficiency. Additionally, JD Health’s extensive logistics network ensures timely and secure delivery of medications, enhancing user experience and building trust.
(vivian.yang@jd.com)
JD.com Dispatches Over 1,000 Couriers from Nationwide to Ensure Last-mile Delivery in Beijing
